biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by jdstoxon Jun 17, 2020 11:56am

245 Views

Post# 31160457

RE:RE:RE:RE:RE:RE:RE:Coverage

I've never had a lot of faith in the knowledge and judgement of the masses, minedigger. What do you think the market "knows" about Bioasis?

One thing I know about speculative stocks, it's unlikely you can make big bucks on one if you believe what the market "knows." What the market "knows" is what controls the share price. This forum is a perfect example of a group of people who post about the possible/probable failure of Bioasis, a belief that has been shared by the market.

It's the divergence of opinion that makes opportunities like Bioasis possible. If the entire market agreed with me, the share prce would be a lot higher.

Bullboard Posts

5 steps to mastering risk management in the stock market